Advanced Wound Care Portfolio
Amniotic membranes, antimicrobial matrices, bioengineered solutions and point-of-care autologous products — distributed by RevivaMed Solutions for clinical teams, providers and distribution partners.
Sizes and SKUs below reflect the current product catalog. Confirm availability against current manufacturer documentation before ordering.
Download product catalog (PDF)Human amniotic-membrane tissue allografts used as barriers and protective coverings for wounds and, for the ocular product, the ocular surface.
Dual-layer amnion-amnion
Barrier and protective covering for wounds.
| Size (cm) | SKU | Wound coverage |
|---|---|---|
| 1×1 | MW0101 | 1 cm² |
| 2×2 | MW0202 | 4 cm² |
| 2×3 | MW0203 | 6 cm² |
| 4×4 | MW0404 | 16 cm² |
| 4×6 | MW0406 | 24 cm² |
| 4×8 | MW0408 | 32 cm² |
| 6×8 | MW0608 | 48 cm² |
| 10×10 | MW1010 | 100 cm² |
Single-layer amnion
Barrier and protective covering for wounds.
| Size (cm) | SKU | Wound coverage |
|---|---|---|
| 6×8 | ML0608 | 48 cm² |
| 8×8 | ML0808 | 64 cm² |
| 10×10 | ML1010 | 100 cm² |
| 20×15 | ML2015 | 300 cm² |
| 20×24 | ML2024 | 480 cm² |
Triple-layer amnion-chorion-amnion
Barrier and protective covering for wounds.
| Size (cm) | SKU | Wound coverage |
|---|---|---|
| 1×1 | TM0101 | 1 cm² |
| 2×2 | TM0202 | 4 cm² |
| 2×3 | TM0203 | 6 cm² |
| 4×4 | TM0404 | 16 cm² |
| 4×6 | TM0406 | 24 cm² |
| 4×8 | TM0408 | 32 cm² |
| 6×8 | TM0608 | 48 cm² |
| 10×10 | TM1010 | 100 cm² |
| 20×15 | TM2015 | 300 cm² |
| 20×24 | TM2024 | 480 cm² |
Hydrated dual-layer amnion-amnion
Hydrated tissue product providing a barrier and protective covering.
| Size (cm) | SKU | Wound coverage |
|---|---|---|
| 2×2 | HM0202 | 4 cm² |
| 2×3 | HM0203 | 6 cm² |
| 4×4 | HM0404 | 16 cm² |
| 4×6 | HM0406 | 24 cm² |
| 4×8 | HM0408 | 32 cm² |
| 6×8 | HM0608 | 48 cm² |
| 10×10 | HM1010 | 100 cm² |
| 20×15 | HM2015 | 300 cm² |
| 20×24 | HM2024 | 480 cm² |
Listed separately from Membrane Wrap - Amniotic Hydro™; the two descriptions are not interchangeable.
Dual-layer amnion hydrated with amniotic fluid
Barrier and protective covering for wounds.
Hydrated with amniotic fluid — distinct from Membrane Wrap - Hydro™, which is a hydrated dual-layer amnion-amnion allograft.
Single-layer amnion
Protective covering of the ocular surface.
Fully synthetic antimicrobial matrices, including a version that releases a uniform unit-dose of lidocaine HCl.
Synthetic antimicrobial matrix
Designed to conform to wound-bed micro-crevices, maintain a moist healing environment, and sustain consistent reduction of microbial burden.
| Size (cm) | SKU | Wound coverage |
|---|---|---|
| 16 mm disc | I-ML16DISC | 2 cm² |
| 2×2 | I-ML0202 | 4 cm² |
| 3×3 | I-ML0303 | 9 cm² |
| 4×4 | I-ML0404 | 16 cm² |
| 5×5 | I-ML0505 | 25 cm² |
| 6×8 | I-ML0608 | 48 cm² |
| 10×10 | I-ML1010 | 100 cm² |
Synthetic antimicrobial matrix with lidocaine HCl
Simultaneous antimicrobial activity and pain relief, with the matrix releasing a uniform, unit-dose of lidocaine HCl.
| Size (cm) | SKU | Wound coverage | Lidocaine / piece |
|---|---|---|---|
| 3×3 | I-MLPG0303 | 9 cm² | 3.6 mg |
| 5×5 | I-MLPG0505 | 25 cm² | 10 mg |
| 10×10 | I-MLPG1010 | 100 cm² | 40 mg |
A biomaterial built around the healing process, combining a collagen derivative, Manuka honey and hydroxyapatite.
Collagen derivative + Manuka honey + hydroxyapatite (MX® technology)
A bioengineered wound product built around MX® technology — a reconstruction of natural elements into a biomaterial designed around the healing process.
| Size (cm) | SKU | Wound coverage |
|---|---|---|
| 1.6×1.6 | APIS-16x16-2 | 3 cm² |
| 2.5×2.5 | APIS-25x25-2 | 6 cm² |
| 4.0×4.0 | APIS-40x40-2 | 16 cm² |
| 5.0×5.0 | APIS-50x50-2 | 25 cm² |
| 6.0×8.0 | APIS-60x80-2 | 48 cm² |
Indications listed in the source flyer: full- and partial-thickness wounds, pressure ulcers (stages I–IV), venous stasis ulcers, diabetic ulcers, surface wounds, traumatic wounds healing by secondary intention, surgical wounds, abrasions and donor-site wounds.
Point-of-care products prepared from a small sample of the patient's own peripheral blood during a dressing session.
Autologous whole blood clot technology
A self-supporting autologous whole blood clot prepared at point of care during a wound dressing session, intended to support the wound-healing process in chronic and hard-to-heal wounds.
Medicare billing reference only: G0465 for diabetic chronic wounds/ulcers, G0460 for non-diabetic chronic wounds/ulcers. Coverage and coding must be confirmed with the applicable MAC.
Tell us which products and sizes you use and where you operate — we'll follow up with current options.
